Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€75.26

€75.26

4.530%
3.26
4.530%
€81.65
 
19:11 / Tradegate WKN: A1W1KK / Symbol: CYTK / Name: Cytokinetics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Cytokinetics

sharewise wants to provide you with the best news and tools for Cytokinetics, so we directly link to the best financial data sources.

News

Cytokinetics Says MYKORZO Launch Tops Expectations as HCM Data Draws Praise
Cytokinetics Says MYKORZO Launch Tops Expectations as HCM Data Draws Praise

Key Points

Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market
Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market

On Feb. 5, 2026, Andrew Callos, Executive Vice President and Chief Commercial Officer of Cytokinetics (NASDAQ:CYTK), exercised 15,000 options for common stock and immediately sold the resulting